These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers. Koszycki D; Bradwejn J; Bourin M Eur Neuropsychopharmacol; 1991 May; 1(2):137-41. PubMed ID: 1821703 [TBL] [Abstract][Full Text] [Related]
31. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males. Goettel M; Fuertig R; Mack SR; Just S; Sharma V; Wunder A; den Boer J CNS Drugs; 2023 Dec; 37(12):1099-1109. PubMed ID: 38019356 [TBL] [Abstract][Full Text] [Related]
32. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Ströhle A; Holsboer F; Rupprecht R Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152 [TBL] [Abstract][Full Text] [Related]
33. Sensitivity to cholecystokinin-tetrapeptide in major depression. Koszycki D; Copen J; Bradwejn J J Affect Disord; 2004 Jun; 80(2-3):285-90. PubMed ID: 15207943 [TBL] [Abstract][Full Text] [Related]
34. 10 microg CCK-4 premedication and 35% CO2 challenge in healthy volunteers. Schruers K; Pols H; Overbeek T; Griez E Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):409-18. PubMed ID: 10836489 [TBL] [Abstract][Full Text] [Related]
35. The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder. van Megen HJ; Westenberg HG; Den Boer JA; Kahn RS Eur Neuropsychopharmacol; 1996 Aug; 6(3):187-94. PubMed ID: 8880078 [TBL] [Abstract][Full Text] [Related]
36. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects. Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429 [TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Bradwejn J; Koszycki D; Meterissian G Can J Psychiatry; 1990 Feb; 35(1):83-5. PubMed ID: 2180549 [TBL] [Abstract][Full Text] [Related]
38. Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteers. Shlik J; Zhou Y; Koszycki D; Vaccarino FJ; Bradwejn J J Psychopharmacol; 1999 Dec; 13(4):385-90. PubMed ID: 10667615 [TBL] [Abstract][Full Text] [Related]
39. The 5-HTTLPR genotype modulates heart rate variability and its adjustment by pharmacological panic challenge in healthy men. Agorastos A; Kellner M; Stiedl O; Muhtz C; Becktepe JS; Wiedemann K; Demiralay C J Psychiatr Res; 2014 Mar; 50():51-8. PubMed ID: 24342768 [TBL] [Abstract][Full Text] [Related]
40. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4). Zwanzger P; Eser D; Völkel N; Baghai TC; Möller HJ; Rupprecht R; Padberg F Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]